Meta AnalysisID 6929

菜蓟(Cynara scolymus L.)对心血管代谢结局的影响:随机对照试验的更新Meta分析和Meta回归

CRD42023421339

To determine the efficacy and safety of Cynara scolymus on blood glucose, lipid level, blood pressure and anthropometric parameters outcomes.

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Herb: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
6929
Evidence Id
15487
Core Evidence Id
15487
Source Meta Analysis Id
6914
Herb2 Meta Analysis Id
HBMA006914
Crd Id
CRD42023421339
Title
Effect of Cynara scolymus L. on cardiometabolic outcomes: An update meta-analysis of randomizedcontrolled trials and meta-regression
Review Question
To determine the efficacy and safety of Cynara scolymus on blood glucose, lipid level, blood pressure and anthropometric parameters outcomes.
Study Type Included
Inclusion criteria: randomized controlled trials (RCTs) that demonstrated the effectiveness of artichoke for any outcome, including lipid profile, blood glucose, blood pressure, and anthropological parameters. Exclusion criteria: pre-post study, and non-RCT observational or cross-sectional study.
Condition Being Studied
1. Blood glucose outcomes including fasting plasma glucose (FPG), HbA1C and Homeostasis model assessment of insulin resistance (HOMA-IR) of participants who use Cynara scolymus products. 2. Lipid profiles outcomes including LDL, HDL, triglyceride (TG), total cholesterol (TC) of participants who use Cynara scolymus products. 3. Blood pressure including systolic blood pressure (SBP) and diastolic blood pressure (DBP) of participants who use Cynara scolymus products. 4. Anthropometric parameters including body weight and body mass index (BMI) 5. Adverse events of participants who use Cynara scolymus products.
Participant
Inclusion criteria: all participants who use Cynara scolymus products including blood glucose, lipid profile, blood pressure and other conditions including body weight and body mass index reduction
Animal
Human Disease Modelled
Intervention
Inclusion criteria: the use of Cynara scolymus products in oral forms. Exclusion criteria: none.
Comparator Control
Inclusion criteria: any comparator or control product incorporates in control or non-intervention group. Exclusion criteria: none.
Main Outcome
Mean and standard deviations laboratory test of blood glucose, lipid profile, blood pressure and anthropometric parameters of participants after use Cynara scolymus products. Measures of effect Standardized mean difference (SMD) and 95% confident interval
Outcome Measure
Additional Outcome
Any adverse effect reported in included trials. Measures of effect Relative risk (RR) and 95% confident interval
Study Method
Meta-analysis, Systematic review
Keyword
Anthropometry; Cardiovascular Diseases; Cynara scolymus; Glucose; Humans; Lipids
Contact
Wiraphol Phimarn [email protected]
Organisational Affiliation
Mahasarakham University https://pharmacy.msu.ac.th/
Funding Source
Mahasarakham University Grant number(s) State the funder, grant or award number and the date of award 2566
Other Selection Criteria
Final Publication
Same Topic Review
Published Protocol
Review Type
Language
English
Country
Thailand
Review Stage
Review Ongoing
First Submission Date
2023-04-25
Registration Date
2023-05-06
Anticipated Start Date
2023-04-25
Anticipated Completion Date
2023-07-31
Title Cn
菜蓟(Cynara scolymus L.)对心血管代谢结局的影响:随机对照试验的更新Meta分析和Meta回归
Title En
Effect of Cynara scolymus L. on cardiometabolic outcomes: An update meta-analysis of randomizedcontrolled trials and meta-regression
Bilingual Status
complete